Brief: Dermata Therapeutics Inc - Expects Its Current Cash Resources Are Sufficient To Fund Operations Into The Third Quarter Of 2023 - Filing

Dermata Therapeutics

10/11/2022 22:47

Nov 10 (Reuters) - Dermata Therapeutics Inc  DRMA.O :
    * DERMATA THERAPEUTICS INC - EXPECTS ITS CURRENT CASH
RESOURCES
ARE SUFFICIENT TO FUND OPERATIONS INTO THE THIRD QUARTER OF 2023
    * DERMATA THERAPEUTICS INC - DMT310 PHASE 2 TOPLINE RESULTS
IN
MODERATE-TO-SEVERE ROSACEA ANTICIPATED IN DECEMBER 2022
    * DERMATA THERAPEUTICS INC - INITIATION OF DMT310 PHASE 3
FOR
MODERATE-TO-SEVERE ACNE EXPECTED IN 1H 2023
    * DERMATA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.20

Further company coverage:  DRMA.O 
 ((Reuters.Briefs@thomsonreuters.com;;))